Given that the worlds second wealthiest man has publicly cited Ozempic and Wegovy brand names for the breakthrough drug semaglutide, approved for the treatment of type 2 diabetes and obesity respectively as his weight loss weapon of choice, its not entirely libellous to assume that at least some of his A-list peers have the same prescription to thank for their increasingly svelte physiques
Daily oral Wegovy offers an attractive alternative for Morgan City residents seeking semaglutide for weight loss
Cipriani A, Saunders K, Attenburrow MJ, Stefaniak J, Panchal P, Stockton S, et al
It mimics endogenous glucagon-like peptide-1 (GLP-1), yet with enhanced pharmacokinetic durability
Publicly posted online, the ad is one of a number of spots by health brands set to air during the game along with those from Pfizer and Novartis